FDA NDC Directory · JSON-LD · Markdown

fondaparinux sodium

NDC 11797-155 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerItalfarmaco S.p.A
Marketing categoryAbbreviated NDA (generic) · App ANDA208615
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsFONDAPARINUX SODIUM (5 mg/.4mL)
Marketing started20190206
Package count2

External sources

Source: openFDA. Public-domain (CC0).